Caption Management, LLC Bio N Tech Se Put Options Transaction History

Caption Management, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2024 Feb 14, 2025	BUY	$99.72 - $122.68 $2.49 Million - $3.07 Million	25,000 New	25,000 $2.85 Million
Q1 2022 May 13, 2022	SELL	$126.25 - $231.85 $1.58 Million - $2.9 Million	-12,500 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$205.93 - $447.23 $2.57 Million - $5.59 Million	12,500 New	12,500 $3.41 Million
Q4 2020 Feb 16, 2021	SELL	$72.71 - $129.54 $24.1 Million - $42.9 Million	-331,400 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$57.81 - $104.17 $19.2 Million - $34.5 Million	331,400 New	331,400 $22.9 Million

363

39.6M

3.01M

2.01M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $27.9B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.